Hans‐Georg Kopp - Researcher Profile

Publications

2 shown

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Salah‐Eddin Al‐Batran , Nils Homann , Claudia Pauligk +54 more

2019 The Lancet 2355 citations

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

Howard West , Michael McCleod , Maen Hussein +17 more

Atezolizumab (a monoclonal antibody against PD-L1), which restores anticancer immunity, improved overall survival in patients with previously treated non-small-cell lung cancer ...

2019 The Lancet Oncology 1597 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 3,952
Institution: Robert Bosch Hospital

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-0825-8888

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.